Repare Therapeutics Inc Sustainability Reports
Repare Therapeutics Inc. is a precision oncology company that discovers and develops targeted cancer therapies using synthetic lethality. The company systematically targets genomic instability and DNA damage repair pathways utilizing its CRISPR-enabled platforms.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
FIGI: BBG00V5N3XG2
1 reports from 2023 to 2023
Company Profile
Repare Therapeutics Inc. is a precision oncology company that discovers and develops targeted cancer therapies using synthetic lethality. The company systematically targets genomic instability and DNA damage repair pathways utilizing its CRISPR-enabled platforms.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years